To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
Management of biologic DMARDs in patients undergoing orthopaedic surgery is variable; flare avoidance is a priority.
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2021
|